Table 1 Episode characteristics by patient diagnosis in the efficacy population

N, patients

4

21

16

28

13

41

Gender

 Male

2

9

11

14

8

22

 Female

2

12

5

14

5

19

N, episodes

4

25

19

29^a

19

48

Median age at episode, days

7 (neonate)

5 (neonate)

6.5 (neonate)

6

387

6.0 (neonate)

387.0 (non-neonate)

Median age at episode, months

44.84 (non-neonate)

2.53 (non-neonate)

12.73 (non-neonate)

0.20

12.73

0.2 (neonate)

12.73 (non-neonate)

 Mean, days (SD)

5.0 (1.8)

7.8 (6.0)

9.8 (10.5)

6.6 (4.8)

11.0 (10.8)

8.4 (7.9)

 Median, days

5.0

7.0

6.0

6.0

7.0

6.0

 Range, days

3–7

2–26

2–43

2–20

3–43

2–43

Concomitant treatment^b (%)

0 (0.0)

12 (48.0)

9 (47.4)

18 (62.1)

3 (15.8)

21 (43.8)

Scavengers

0

9

6

13

2

15

Haemodialysis/haemofiltration

0

3

3

5

1

6

 Mean (SD)

666.8 (692.2)

296.9 (206.2)

355.0 (326.8)

468.3 (365.3)

171.3 (75.7)

350.7 (321.3)

 Median

435.0

247.8

213.0

328.0

164.0

215.0

 Range

164.0–1633.0

76.1–868.0

76.0–1200.0

96.0–1633.0

76.0–385.0

76.0–1633.0